The impact of the metabolic syndrome on health-related quality of life: A cross-sectional study in Greece
Φόρτωση...
Ημερομηνία
Συγγραφείς
Tziallas, D.
Kastanioti, C.
Kostapanos, M. S.
Skapinakis, P.
Elisaf, M. S.
Mavreas, V.
Τίτλος Εφημερίδας
Περιοδικό ISSN
Τίτλος τόμου
Εκδότης
Περίληψη
Τύπος
Είδος δημοσίευσης σε συνέδριο
Είδος περιοδικού
peer-reviewed
Είδος εκπαιδευτικού υλικού
Όνομα συνεδρίου
Όνομα περιοδικού
Eur J Cardiovasc Nurs
Όνομα βιβλίου
Σειρά βιβλίου
Έκδοση βιβλίου
Συμπληρωματικός/δευτερεύων τίτλος
Περιγραφή
BACKGROUND: Metabolic syndrome [MetS] is a chronic, progressive and multi-complex health problem that can trigger physical, emotional and psychosocial problems. The aim of this study is to investigate the association between MetS and health-related quality of life (HRQoL) as well as depressive and anxiety disorders. METHODS: New consecutive patients who attended an outpatient lipid clinic for evaluation for MetS were eligible for inclusion in the study. The MetS was defined according to the new definition of International Diabetes Federation (IDF). The Medical Outcomes Study, Short Form-36 (SF-36) was used to assess HRQoL. Anxiety and depressive symptoms were assessed by a validated Greek version of the Hospital Anxiety and Depression Scale (HADS). RESULTS: Three hundred and fifty-nine subjects were involved of whom 206 [57.4%] met the diagnostic criteria for the MetS (cases) and 153 [42.6%] were free of MetS criteria (comparator group). MetS was associated with lower scores of all subscales of the SF-36 except of bodily pain. The physical component summary score of SF-36 was independently associated with gender (beta=2.41, P=.01), married or living together (beta=5.18, P=.001) and satisfactory household income (beta=5.77, P<.0001). The mental component summary score of SF-36 was independently associated with gender (beta=3.20, P=.003) and satisfactory household income (beta=3.94, P=.02). A predominance of anxiety and depressive symptoms was observed among subjects with MetS. CONCLUSIONS: Our study demonstrated that subjects with MetS have significantly more impaired HRQoL than those without MetS. These findings suggest that HRQoL should be considered in the management of subjects with MetS.
Περιγραφή
Λέξεις-κλειδιά
Θεματική κατηγορία
Παραπομπή
Σύνδεσμος
http://www.ncbi.nlm.nih.gov/pubmed/21398183
http://ac.els-cdn.com/S147451511100034X/1-s2.0-S147451511100034X-main.pdf?_tid=0719e5829285a780eec065774d152d7e&acdnat=1332941283_9f0391573eb29decaf85f974ac330e09
http://ac.els-cdn.com/S147451511100034X/1-s2.0-S147451511100034X-main.pdf?_tid=0719e5829285a780eec065774d152d7e&acdnat=1332941283_9f0391573eb29decaf85f974ac330e09
Γλώσσα
en
Εκδίδον τμήμα/τομέας
Όνομα επιβλέποντος
Εξεταστική επιτροπή
Γενική Περιγραφή / Σχόλια
Ίδρυμα και Σχολή/Τμήμα του υποβάλλοντος
Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής